ZTS Q4 2020 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

Q4 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.8B+7.9% YoY

Gross Profit

$1.2B64.5% margin

Operating Income

$513M28.4% margin

Net Income

$359M19.9% margin

EPS (Diluted)

$0.75

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

$718M

Free Cash Flow

$574M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$13.6B

Total Liabilities

$9.8B

Stockholders' Equity

$3.8B

Cash & Equivalents

$3.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.8B	$1.7B	+7.9%
Gross Profit	$1.2B	$1.1B	+5.6%
Operating Income	$513M	$500M	+2.6%
Net Income	$359M	$384M	-6.5%

Revenue Segments

Horses

$3.3B81%

Cattle

$451M11%

Swine

$167M4%

Poultry

$125M3%

Fish

$47M1%

Geographic Segments

United States Segment

$952M53%

International Segment

$832M47%